Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Return on Equity: 2021-2025

Historic Return on Equity for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to 0.45%.

  • Pharming Group N.V's Return on Equity rose 58.00% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year increase of 58.00%. This contributed to the annual value of -0.05% for FY2024, which is 4.00% down from last year.
  • As of Q3 2025, Pharming Group N.V's Return on Equity stood at 0.45%, which was up 3,446.34% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Return on Equity registered a high of 0.45% during Q3 2025, and its lowest value of -0.16% during Q2 2024.
  • For the 3-year period, Pharming Group N.V's Return on Equity averaged around -0.03%, with its median value being -0.11% (2023).
  • Per our database at Business Quant, Pharming Group N.V's Return on Equity crashed by 56bps in 2023 and then skyrocketed by 58bps in 2025.
  • Pharming Group N.V's Return on Equity (Quarterly) stood at 0.03% in 2021, then skyrocketed by 31bps to 0.34% in 2022, then plummeted by 44bps to -0.10% in 2023, then declined by 2bps to -0.12% in 2024, then surged by 58bps to 0.45% in 2025.
  • Its Return on Equity was 0.45% in Q3 2025, compared to 0.01% in Q2 2025 and -0.12% in Q4 2024.